期刊文献+

呼吸科院内尿路感染患者病原菌及耐药分析 被引量:4

Distribution and resistance of pathogenic bacteria in patients with nosocomial urinary tract infections
下载PDF
导出
摘要 目的分析呼吸科院内尿路感染患者的病原菌种类分布及其耐药性,为合理用药提供参考。方法回顾性分析呼吸科明确诊断的院内尿路感染患者35例,分析其尿培养病原菌结果。结果 35例患者共分离出58株病原菌,其中革兰阴性菌27株,占46.55%,革兰阳性菌10株,占17.24%,真菌21株,占36.21%。病原菌按检测率排序前3位依次是大肠埃希菌(18.97%)、白色念珠菌(17.24%)、肺炎克雷伯杆菌(10.34%),药物敏感试验显示:革兰阴性菌及革兰阳性菌耐药性严重。结论呼吸科院内尿路感染病原菌以革兰阴性菌为主,且呈多重耐药现象。真菌感染检出率明显增高,临床需加以重视。 Objective To analyze the distribution and drug resistance of the pathogenic bacteria in patients with nosocomial urinary tract infections.Methods The results of urine culture in 35 patients with nosocomial urinary tract infection were analyzed.Results There were 58 strains of pathogenic bacteria isolated,including 27 strains of Gram-negative bacteria (46.55%),1 0 strains of Gram-positive bacteria (1 7.24%),and 21 strains of fungi (36.21%).The top three pathogens were escherichia coli (1 8.97%),Candida albicans (1 7.24%)and Klebsiella pneumoniae (1 0.34%).Drug sensitivity test showed that high drug resistance occurred in both Gram-negative bacte-ria and Gram-positive bacteria.Conclusion Nosocomial urinary tract infection in respiratory department is mainly caused by Gram-negative bacteria,showing multi-drug resistance.Fungal infection shows a higher detection rate, which should be paid more attention in clinic.
作者 刘宇
出处 《临床肺科杂志》 2015年第2期303-305,共3页 Journal of Clinical Pulmonary Medicine
关键词 尿路感染 病原菌 耐药性 urinary tract infection pathogen drug resistance
  • 相关文献

参考文献9

二级参考文献59

共引文献144

同被引文献39

  • 1廖万清,顾菊林.真菌耐药的现状与对策[J].药学服务与研究,2006,6(3):161-164. 被引量:13
  • 2刘香梅,张钰,闵凡贵,赵维波,刘忠华,黄韧.环磷酰胺对近平滑念珠菌感染小鼠白细胞的影响[J].实验动物与比较医学,2007,27(2):116-118. 被引量:4
  • 3刘永惠.刘茂甫教授用补肾化瘀法治疗老年期尿路感染的经验总结[C].中华中医药学会第二十六次肾病分会学术交流会议,2013.
  • 4Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality[ J]. Antimicrobial Agents and Chemotherapy, 2005, 49 (9): 3640 -3645.
  • 5Zaoutis TE, Argon J, Chu J, et al. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis [ J ]. clinical infectious diseases, 2005,41 ( 9 ) : 1232 - 1239.
  • 6Horn DL. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospeetive antifungal therapy alliance registry[ J ]. clinical infectious diseases, 2009,48 ( 12 ) : 1695 - 1703.
  • 7Franz R, Kelly SL, Lamb DC, et al. Multiple Molecular Mechanisms Contribute to a Stepwise Development of Fluconazole Resistance in Clinical C andida albieans Strains[ J ]. Antimicrobial agents chemotherapy, 1998,42 (12) : 3065 - 3072.
  • 8Zhang L, Yan K, Zhang Y, et al. High-throughput synergy screening identifies icrobial metabolites as combination agents or the treatment of fungal infections [ J ]. PANS, 2007,104 ( 11 ) : 4606 - 4611.
  • 9杨鸿霜,孙海燕.危重患者深部真菌感染的现状分析及防治对策[J].临床肺科杂志,2011,16(6):848-849. 被引量:8
  • 10魏宏莲,时东彦,宋文杰,李继红,孙倩,李凤君.2009~2010年医院内假丝酵母菌的临床分布及耐药性分析[J].临床荟萃,2011,26(12):1080-1081. 被引量:2

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部